NCT00110955View on ClinicalTrials.gov

Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

PHASE3CompletedINTERVENTIONAL
Enrollment

391

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

March 31, 2005

Study Completion Date

April 30, 2005

Conditions
AnemiaNon-Myeloid Malignancies
Interventions
DRUG

Darbepoetin alfa

Q3W 300 mcg darbepoetin alfa

DRUG

Placebo

Q3W dosing of placebo

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00110955 - Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy | Biotech Hunter | Biotech Hunter